DAFTAR ISI

Halaman

JUDUL

KATA PENGANTAR .......................................................................... i

DAFTAR ISI ......................................................................................... ii

BAB I PENDAHULUAN

Latar Belakang ..................................................................................... 1

1.1 Rumusan Masalah .......................................................................... 4

1.2 Tujuan Penelitian ............................................................................ 4

1.2.1 Tujuan umum ....................................................................... 4

1.2.2 Tujuan khusus ..................................................................... 4

1.3 ManfaatPenelitian ........................................................................... 5

1.3.1 Manfaat teoritis .................................................................... 5

1.3.2 Manfaat Aplikatif .................................................................. 5

BAB II TINJAUAN PUSTAKA

2.1 Profil UPT Puskesmas Sukmajaya ................................................ 6

2.1.1 Profil Geografis ................................................................... 6

2.1.2 Struktur Organisasi dan Tata Kerja ..................................... 7

2.1.3 Sumber Daya Kesehatan .................................................... 8

2.1.4 Visi dan Misi ........................................................................ 10

2.1.4 Tujuan ................................................................................. 10

2.1.4 Tata Kerja ........................................................................... 10

2.1.5 Kebijakan Mutu ................................................................... 28

ii
2.2 Pengguna Narkoba Suntik ............................................................ 11

2.3 Program Terapi Rumatan Metadon ................................................ 12

2.3.1 Pengertian Metadon ............................................................. 12

2.3.2 Farmakologi ........................................................................ 12

2.3.3 Indikasi ................................................................................ 15

2.3.4 Sediaan dan Dosis .............................................................. 15

2.3.5 Efek Samping ...................................................................... 21

2.3.6 Gejala dan Tanda Paien Metadon ...................................... 22

2.3.7 Toleransi dan Kemungkinan Adiksi ..................................... 23

2.3.8 Interaksi Obat ...................................................................... 23

2.3.9 Kontraindikasi ..................................................................... 24

2.3.10 Over Dosis ........................................................................ 24

2.3.11Perhatian Khusus ............................................................... 25

BAB III METODELOGI PENELITIAN

3.1 Jenis Penelitian .............................................................................. 26

3.2 Tempat dan Waktu Penelitian ........................................................ 26

3.3 Subjek Penelitan ............................................................................ 26

3.4 Kriteria Seleksi ............................................................................... 26

3.5 Sampling dan Teknik Sampling...................................................... 27

3.6 Definisi Operassional Variabel ....................................................... 27

3.7 Intrumen Penelitian ........................................................................ 28

3.8 Prosedur Penelitan ........................................................................ 29

3.9 Pengumpulan Data dan Analisis .................................................... 29

3.10 Etika Penelitian ............................................................................ 29

iii
BAB IV HASIL PENELITIAN

4.1 Hasil Penelitian .............................................................................. 30

4.2 Analisis Deskriptif ........................................................................... 30

4.2.1 Karakteristik Responden........................................................ 30

4.2.2 Distribusi Berdasarkan Tingkat Retensi ................................ 31

4.2.2 Distribusi Berdasarkan Drop Out dalam PTRM .................... 32

4.2.2 Distribusi Berdasarkan Tatalaksana Dosis Rumatan ........... 32

4.2.2 Distribusi Berdasarkan Tahap Pemberian Dosis .................. 33

BAB V PEMBAHASAN

5.1 Pembahasan .................................................................................. 35

BAB VI KESIMPULAN DAN SARAN

6.1 Kesimpulan ...................................................................... 39

6.2 Saran................................................................................ 39

DAFTAR PUSTAKA ........................................................................... 41

LAMPIRAN

iv